Supplementary information regarding order from National Institutes of Health

The HoloMonitor unit purchased for a retail price by National Institutes of Health (NIH) has been delivered and sold by PHI Inc. in Boston Massachusetts, USA, a fully owned subsidiary to Phase Holographic Imaging PHI AB. 

The order is the result of NIH's non-competitive procurement of HoloMonitor, which the company announced on September 11, 2019.

For additional information, please contact:
Carolina Silvandersson
E-mail: ir@phiab.se
Web: www.phiab.com – Live cell imaging & analysis

Phase Holographic Imaging (PHI) leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.